SynthesisJournal of cancer research and clinical oncology2013

PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.

Shuangjie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.